A comprehensive view of Sexually Transmitted Diseases (STDs). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Department of Health and Human Services launches the National Syphilis and Congenital Syphilis Syndemic (NSCSS) Federal Task Force in response to surging number of syphilis and congenital syphilis cases nationwide; cases are highest since 1950s
Published: January 30, 2024 by U.S. Dept. of Health and Human Services (HHS)
Morningstar names Gilead a top dividend stock, noting stellar profit margins with HIV/hepatitis C virus portfolio, which requires small salesforce and inexpensive manufacturing; however, smart future acquisitions among factors needed to return to growth
Published: January 22, 2024 by Victoria Advocate
French firm Laboratoires Delbert to temporarily import syphilis treatment to the US amidst rising cases and a shortage of Pfizer's Bicillin; the firm is working with the FDA to import 3.6 million units of Extencilline
Published: January 12, 2024 by FiercePharma
FDA authorizes LetsGetChecked's Simple 2 test available online without a prescription that provides at-home sample collection for testing for chlamydia and gonorrhea; test samples are sent to a laboratory for testing and results are delivered online
Published: November 16, 2023 by MedTech Dive
UBS assumes coverage on Merck with buy rating and US$122 target, expects consensus upgrades for Keytruda and Gardasil in 2024; highlights include underappreciated pipeline opportunities like PRA023 in ulcerative colitis, gefapixant in chronic cough
Published: October 20, 2023 by Investing.com

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count